Domainex

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years. Domainexs highly experienced molecular, protein, structural and assay biologists plus medicinal, computational and analytical chemists can be leveraged through our CRO services. Domainexs focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets....

Drug discovery,medicinal chemistry,molecular biology,computational chemistry,assay biology,analytical chemistry,x-ray crystallography,cell biology,oncology,kinase inhibitor research,protease inhibitor research,fragment screening,virtual screening,protein-protein interactions,gpcrs,biochemistry,biophysics,inflammatory diseases,cryo-em,and protein production

Domainex operates in the Biotechnology research industry.

Domainex's revenue is $15.10m

Domainex has 51 - 200 employees.